Evidence map›Paper›PMID 30167989›Full record

ArticleThe journal of headache and pain2018

New CACNA1A deletions are associated to migraine phenotypes.

G S Grieco, S Gagliardi, I Ricca, O Pansarasa, M Neri, F Gualandi, G Nappi, A Ferlini, C Cereda

Open access · goldAbstract read
In one paragraph

Article in The journal of headache and pain, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. A Review of theDiseases (Basel, Switzerland) · 2024
    Review
  3. Review
  4. EDIR: exome database of interspersed repeats.Bioinformatics (Oxford, England) · 2023
    Article
  5. Towards Zebrafish Models of CNS Channelopathies.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Diagnostic and therapeutic aspects of hemiplegic migraine.Journal of neurology, neurosurgery, and psychiatry · 2020
    Review
  8. Article
  9. Article
  10. Advances in genetics of migraine.The journal of headache and pain · 2019
    Review
  11. Zebrafish as a Model System for the Study of Severe CaFrontiers in molecular neuroscience · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

G S GriecoIRCCS Mondino Foundation, Genomic and post-Genomic Center, Pavia, Italy.
S GagliardiIRCCS Mondino Foundation, Genomic and post-Genomic Center, Pavia, Italy. stella.gagliardi@mondino.it.ORCID http://orcid.org/0000-0002-6589-6907
I RiccaIRCCS Mondino Foundation, Genomic and post-Genomic Center, Pavia, Italy.
O PansarasaIRCCS Mondino Foundation, Genomic and post-Genomic Center, Pavia, Italy.
M NeriUnit of Medical Genetics, S. Anna University-Hospital, Ferrara, Italy.
F GualandiUnit of Medical Genetics, S. Anna University-Hospital, Ferrara, Italy.
G NappiIRCCS Mondino Foundation, Headache Science Center, Pavia, Italy.
A FerliniUnit of Medical Genetics, S. Anna University-Hospital, Ferrara, Italy.
C CeredaIRCCS Mondino Foundation, Genomic and post-Genomic Center, Pavia, Italy.
Center for Genomic Science · ITUniversity of Ferrara · ITFoundation Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFamilial hemiplegic migraine type 1 (FHM1) is a form of migraine with aura caused by heterozygous mutations in 4 genes: CACNA1A, ATP1A2, SNC1A and PRRT2, but further heterogeneity is expected. Here have been described clinical and molecular features in patients suffering from migraine with Aura (MA), without (MO) and hemiplegic migraine attacks. Next Generation Sequencing by TruSeq Custom Amplicon for CACNA1A and ATP1A2 gene has been performed. All genetic variants have been confirmed by Sanger sequencing and all samples were also analyzed with MLPA assay for ATP1A2-CACNA1A genes to detect duplication or deletion. All MLPA data were verified by Real Time PCR.

resultsSequencing analysis showed 3 point mutations, two novel variants and one already described in literature. Moreover, MLPA analysis showed 3 deletions in 9 sporadic hemiplegic migraine (18%), in 3 patients with non-hemiplegic migraine (4.1%) and in 3 patients affected by episodic ataxia (20%). Two sporadic patients showed a deletion in exons 41-43, while the rest of HM patients (5) showed a deletion in the terminal part of the CACNA1A gene. About episodic ataxia, we have identified deletions in exon 12-15 and in exon 47. Finally, in migraine patients, we have found different subjects affected by different phenotypes deleted in exon 47.

conclusionThis work highlights the importance to complement analysis as direct sequencing with quantitative analysis (MLPA). In fact, intragenic CACNA1A rearrangements have been detected. Our work demonstrated that deletions in CACNA1A gene may be associated also to different migraine phenotypes.

Indexed as

Chromosome DeletionPhenotypeAdultCalcium ChannelsCalcium Channels, N-TypeDNA Mutational AnalysisExonsFemaleHumansMaleMiddle AgedMigraine DisordersPoint MutationSequence Analysis, DNACACNA1A protein, humanCalcium ChannelsCalcium Channels, N-TypeCACNA1ADeletionDe novoMigraine phenotypes

Identifiers

PMID30167989
PMCPMC6117225
OpenAlexW2888816408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.